SCHEMBL23919322

SCHEMBL23919322

Cc1ccc(N(c2ccc3ccc4c(N(c5ccc(C)cc5)c5c(C)ccc6c5sc5ccccc56)ccc5ccc2c3c54)c2c(C)ccc3c2sc2ccccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.33
MAPT P10636 3/20 0.33
ATM Q13315 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
APP P05067 1/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
CHRM1 P11229 1/20 0.32
MAOA P21397 1/20 0.32
DRD1 P21728 1/20 0.32
TBXA2R P21731 1/20 0.32
SLC6A2 P23975 1/20 0.32
APEX1 P27695 1/20 0.32
SLC6A4 P31645 1/20 0.32
ADRA1A P35348 1/20 0.32
OPRM1 P35372 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919324 0.93 MAPT (0.35) L3MBTL1MAPTATMTNKSTNKS2
SCHEMBL23919340 0.91 TNKS (0.33) L3MBTL1MAPTATMTNKSTNKS2
SCHEMBL23919335 0.90 MAPT (0.35) L3MBTL1MAPTATMALDH1A1CYP3A4
SCHEMBL23919417 0.89 TNKS (0.35) L3MBTL1MAPTATMTNKSTNKS2
SCHEMBL23919418 0.89 MAPT (0.33) L3MBTL1MAPTATMAPPCHRM2
SCHEMBL23919325 0.88 MAPT (0.34) L3MBTL1MAPTATMALDH1A1CYP3A4
SCHEMBL17036354 0.88 PRKDC (0.35) PRKDC
SCHEMBL23919420 0.87 MAPT (0.35) L3MBTL1MAPTATMAPPCHRM2
SCHEMBL23919341 0.87 MAPT (0.35) L3MBTL1MAPTATMTNKSTNKS2
SCHEMBL23919333 0.85 APP (0.30) APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 L3MBTL1 2341/4885MAPT 2477/4885ATM 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.